Frontiers in Genetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2021-10-19 HYZ123

Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢

79 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2021-01-14 ms8000001158108441

审稿速度:1.0
经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021

131 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2021-10-24 146f71c6m20暂无昵称

审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0
偏重的研究方向：肿瘤;外科学
经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。

73 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2021-06-08 tracypan

我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…

49 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2022-07-27 ms5000001280844911

偏重的研究方向：基因
经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗

47 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2022-12-10 ms7000000033418611 来自吉林省

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：阿尔兹海默症
经验分享：投稿一篇纯生信，单基因
六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题
之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的
前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警

52 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2022-03-23 446147195_70413606

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;生信
经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢

36 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2021-10-13 ms9000001511018535

审稿速度:1.0 | 投稿命中率:50.0
经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks.
这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？

36 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2023-03-12 董柏来自浙江省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：4个审稿人，纯生信文章，2个半月

56 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1061759, encodeId=10bc1061e59ee, content=Editorial Assignment快一个月了还没送审，请问大家这正常吗？到什么时候催稿问比较合适？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3a05219761, createdName=HYZ123, createdTime=Tue Oct 19 10:15:48 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916440, encodeId=1f6191644004, content=审稿速度:1.0 经验分享：今天文章接收，跟大家分享一下 Received date: 09 Nov 2020 Editorial assignment start date: 10 Nov 2020 Independent review start date: 20 Nov 2020 Interactive review activated date: 18 Dec 2020 Review finalized date: 28 Dec 2020 Final validation date: 13 Jan 2021 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a25408241, createdName=ms8000001158108441, createdTime=Thu Jan 14 09:09:43 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063597, encodeId=fd7f106359eea, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：肿瘤;外科学 经验分享：杂志审稿周期越来越慢，急着毕业的不建议投，生物信息学文章需要实验验证。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5e35180687, createdName=146f71c6m20暂无昵称, createdTime=Sun Oct 24 22:40:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971764, encodeId=07ff9e176465, content=我吐了…投了一篇纯生信编辑说不在scope范围内，推荐帮我转投frontiers in bioinformatic（一个他们刚搞的新期刊）。可是后者还没被sci收录…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95815503851, createdName=tracypan, createdTime=Tue Jun 08 10:13:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235117, encodeId=a67a123511ebb, content=偏重的研究方向：基因 经验分享：一个审稿人拒绝，另一个让小修并且4 4 4 4分，这种是不是修回去也被拒，正常不应该至少两个审稿人同意才可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83675615943, createdName=ms5000001280844911, createdTime=Wed Jul 27 17:53:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105246, encodeId=8cb42105246d8, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：阿尔兹海默症 经验分享：投稿一篇纯生信，单基因 六月份投的，很快邀请了一个审稿人，审稿人也很快回复了，提了几个小问题 之后拖了俩月问让推荐审稿人，后来第二个是自己推荐的 前几天accept了，总体来说还是好中的，毕竟我只是个本科菜鸡，希望别预警, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b47b6157206, createdName=ms7000000033418611, createdTime=Sat Dec 10 15:19:57 CST 2022, time=2022-12-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1205273, encodeId=7fc312052e335, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：竟然五个审稿人意见，几十个问题！！！头一次见，让体内体外验证，只给1周的时间修回！！！搞笑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Wed Mar 23 17:03:53 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060173, encodeId=6f8410601e33d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：The Associate Editor XXX and the Editorial Office are evaluating the revisions made to the manuscript and are performing technical checks. 这种情况况有人遇见过没？是个什么意思，一般不是editor就可以决定拒稿或接收，怎么还需要Editorial Office？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2905512154, createdName=ms9000001511018535, createdTime=Wed Oct 13 17:08:39 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094278, encodeId=766120942e8f4, content=想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cb58350980, createdName=ms5000001613378511, createdTime=Mon Oct 17 17:15:19 CST 2022, time=2022-10-17, status=1, ipAttribution=)]

2022-10-17 ms5000001613378511

想请问大家frontiers in genetics从投稿到分配编辑要多久，分配了编辑送审又要多久呀？

48 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务